We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

173 hedge funds and large institutions have $881M invested in Spectrum Pharmaceuticals Inc in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 76 increasing their positions, 38 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 38

16% more capital invested

Capital invested by funds: $757M → $881M (+$123M)

2% less funds holding

Funds holding: 176173 (-3)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

56% less call options, than puts

Call options by funds: $727K | Put options by funds: $1.66M

Holders
173
Holders Change
-3
Holders Change %
-1.7%
% of All Funds
3.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
76
Reduced
38
Closed
22
Calls
$727K
Puts
$1.66M
Net Calls
-$930K
Net Calls Change
-$336K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Sio Capital Management
New York
$5.92M +$5.93M +554,019 New
PAM
27
Panagora Asset Management
Massachusetts
$5.74M +$1.1M +103,152 +24%
SIG
28
Sargent Investment Group
Maryland
$5.01M +$219K +20,410 +5%
Deutsche Bank
29
Deutsche Bank
Germany
$4.61M +$244K +22,761 +6%
Citadel Advisors
30
Citadel Advisors
Florida
$3.66M +$1.73M +161,935 +90%
Morgan Stanley
31
Morgan Stanley
New York
$3.45M -$3.49M -325,810 -50%
VOYA Investment Management
32
VOYA Investment Management
Georgia
$3.37M -$8M -746,693 -70%
Legal & General Group
33
Legal & General Group
United Kingdom
$3.18M +$450K +42,066 +16%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$3.16M +$62.9K +5,871 +2%
Two Sigma Investments
35
Two Sigma Investments
New York
$2.63M +$2.53M +236,119 +2,270%
JP Morgan Chase
36
JP Morgan Chase
New York
$2.49M -$95K -8,874 -4%
QI
37
QS Investors
New York
$2.37M +$1.39M +129,500 +141%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$2.1M +$2.1M +196,384 New
TCIM
39
TIAA CREF Investment Management
New York
$2.08M -$1.66M -154,914 -44%
AQR Capital Management
40
AQR Capital Management
Connecticut
$2.04M +$975K +91,026 +91%
Fisher Asset Management
41
Fisher Asset Management
Washington
$1.93M
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.88M +$72.8K +6,800 +4%
Prudential Financial
43
Prudential Financial
New Jersey
$1.81M +$43.6K +4,067 +2%
GC
44
Guggenheim Capital
Illinois
$1.79M +$130K +12,179 +8%
AllianceBernstein
45
AllianceBernstein
Tennessee
$1.75M
ASRS
46
Arizona State Retirement System
Arizona
$1.74M +$67.8K +6,331 +4%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.66M -$25.9K -2,414 -2%
SG Americas Securities
48
SG Americas Securities
New York
$1.59M +$1.59M +148,478 New
CAM
49
Congress Asset Management
Massachusetts
$1.57M -$27.4K -2,555 -2%
ACM
50
Ashford Capital Management
Delaware
$1.53M -$1.6M -149,392 -51%

SPPI Hedge Fund Activity: Q1 2019 in Review

173 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2019, worth a combined $881M — up 16% from $757M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SPPI and 19 opened new positions — a net loss of 3 holders — while 38 trimmed existing stakes and 76 added.

The largest buyer was Millennium Management, adding an estimated $9.11M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $26M sold.

  • 173 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2019, down from 176 in Q4 2018.
  • Funds reported $881M of Spectrum Pharmaceuticals Inc stock for Q1 2019, up 16% quarter-over-quarter.
  • 19 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2019 and 22 closed out, a net change of -3 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2019 was Millennium Management, an estimated $9.11M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2019 was Consonance Capital Management, an estimated $26M sold.

Based on aggregated 13F filings for Q1 2019.